Literature DB >> 18425821

On multiple-testing correction in genome-wide association studies.

Valentina Moskvina1, Karl Michael Schmidt.   

Abstract

The interpretation of the results of large association studies encompassing much or all of the human genome faces the fundamental statistical problem that a correspondingly large number of single nucleotide polymorphisms markers will be spuriously flagged as significant. A common method of dealing with these false positives is to raise the significance level for the individual tests for association of each marker. Any such adjustment for multiple testing is ultimately based on a more or less precise estimate for the actual overall type I error probability. We estimate this probability for association tests for correlated markers and show that it depends in a nonlinear way on the significance level for the individual tests. This dependence of the effective number of tests is not taken into account by existing multiple-testing corrections, leading to widely overestimated results. We demonstrate a simple correction for multiple testing, which can easily be calculated from the pairwise correlation and gives far more realistic estimates for the effective number of tests than previous formulae. The calculation is considerably faster than with other methods and hence applicable on a genome-wide scale. The efficacy of our method is shown on a constructed example with highly correlated markers as well as on real data sets, including a full genome scan where a conservative estimate only 8% above the permutation estimate is obtained in about 1% of computation time. As the calculation is based on pairwise correlations between markers, it can be performed at the stage of study design using public databases. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18425821     DOI: 10.1002/gepi.20331

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  115 in total

1.  Evaluating the effective numbers of independent tests and significant p-value thresholds in commercial genotyping arrays and public imputation reference datasets.

Authors:  Miao-Xin Li; Juilian M Y Yeung; Stacey S Cherny; Pak C Sham
Journal:  Hum Genet       Date:  2011-12-06       Impact factor: 4.132

2.  Rapid and robust resampling-based multiple-testing correction with application in a genome-wide expression quantitative trait loci study.

Authors:  Xiang Zhang; Shunping Huang; Wei Sun; Wei Wang
Journal:  Genetics       Date:  2012-01-31       Impact factor: 4.562

3.  Identifying genetic marker sets associated with phenotypes via an efficient adaptive score test.

Authors:  Tianxi Cai; Xihong Lin; Raymond J Carroll
Journal:  Biostatistics       Date:  2012-06-25       Impact factor: 5.899

4.  Powerful SNP-set analysis for case-control genome-wide association studies.

Authors:  Michael C Wu; Peter Kraft; Michael P Epstein; Deanne M Taylor; Stephen J Chanock; David J Hunter; Xihong Lin
Journal:  Am J Hum Genet       Date:  2010-06-11       Impact factor: 11.025

Review 5.  The role of phenotype in gene discovery in the whole genome sequencing era.

Authors:  Laura Almasy
Journal:  Hum Genet       Date:  2012-06-22       Impact factor: 4.132

6.  Recurrent major depression and right hippocampal volume: A bivariate linkage and association study.

Authors:  Samuel R Mathias; Emma E M Knowles; Jack W Kent; D Reese McKay; Joanne E Curran; Marcio A A de Almeida; Thomas D Dyer; Harald H H Göring; Rene L Olvera; Ravi Duggirala; Peter T Fox; Laura Almasy; John Blangero; David C Glahn
Journal:  Hum Brain Mapp       Date:  2015-10-20       Impact factor: 5.038

Review 7.  Dissecting Complex and Multifactorial Nature of Alzheimer's Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective.

Authors:  Puneet Talwar; Juhi Sinha; Sandeep Grover; Chitra Rawat; Suman Kushwaha; Rachna Agarwal; Vibha Taneja; Ritushree Kukreti
Journal:  Mol Neurobiol       Date:  2015-09-09       Impact factor: 5.590

8.  Serum uric acid concentrations and SLC2A9 genetic variation in Hispanic children: the Viva La Familia Study.

Authors:  V Saroja Voruganti; Sandra Laston; Karin Haack; Nitesh R Mehta; Shelley A Cole; Nancy F Butte; Anthony G Comuzzie
Journal:  Am J Clin Nutr       Date:  2015-01-28       Impact factor: 7.045

9.  Genetic variation in the inflammation and innate immunity pathways and colorectal cancer risk.

Authors:  Hansong Wang; Darin Taverna; Daniel O Stram; Barbara K Fortini; Iona Cheng; Lynne R Wilkens; Terrilea Burnett; Karen W Makar; Noralane M Lindor; John L Hopper; Steve Gallinger; John A Baron; Robert Haile; Laurence N Kolonel; Brian E Henderson; Polly A Newcomb; Graham Casey; David Duggan; Cornelia M Ulrich; Loïc Le Marchand
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-17       Impact factor: 4.254

10.  Genetic dissection of the pre-eclampsia susceptibility locus on chromosome 2q22 reveals shared novel risk factors for cardiovascular disease.

Authors:  Matthew P Johnson; Shaun P Brennecke; Christine E East; Thomas D Dyer; Linda T Roten; J Michael Proffitt; Phillip E Melton; Mona H Fenstad; Tia Aalto-Viljakainen; Kaarin Mäkikallio; Seppo Heinonen; Eero Kajantie; Juha Kere; Hannele Laivuori; Rigmor Austgulen; John Blangero; Eric K Moses
Journal:  Mol Hum Reprod       Date:  2013-02-18       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.